Stockscreener 앱 받기
74.75
1.01%
-0.76
시간 외 거래:
74.75
전일 마감가:
$75.51
열려 있는:
$75.09
하루 거래량:
1.87M
Relative Volume:
1.89
시가총액:
$12.84B
수익:
$8.26B
순이익/손실:
$66.00M
주가수익비율:
203.01
EPS:
0.3682
순현금흐름:
$1.17B
1주 성능:
+1.05%
1개월 성능:
-10.41%
6개월 성능:
+10.63%
1년 성능:
+0.00%
1일 변동 폭
$74.54
$75.41
1주일 범위
$73.25
$75.85
52주 변동 폭
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.75 | 12.84B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
VEEV
Veeva Systems Inc
|
234.21 | 38.81B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.51 | 11.36B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
47.83 | 10.16B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
86.96 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
Is Solventum (NYSE:SOLV) Using Too Much Debt? - Simply Wall St
Solventum CEO made $14.8M in first year of 3M spinoff - Star Tribune
Solventum cuts 800 positions - MedTech Dive
Solventum and SprintRay enter dental 3D printing partnership - VoxelMatters
Solventum inks 3D dental printing partnership with SprintRay - Mass Device
Solventum Partners With SprintRay for Quick 3D-Printed Dental Restorations - Marketscreener.com
Solventum partners with SprintRay for dental 3D printing By Investing.com - Investing.com Australia
Solventum partners with SprintRay for dental 3D printing - Investing.com India
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations - Quantisnow
Revolutionary Breakthrough: Solventum and SprintRay Launch Same-Day Permanent Dental Crowns - StockTitan
Solventum paid CEO Bryan Hanson $40M in spinoff’s first year - Medical Design & Outsourcing
3M’s Healthcare Spinoff Stock Fell. This Is What It’s Worth. - MSN
New Solventum layoff details emerge, including 110 Minnesota job cuts - MSN
SEC Form DEF 14A filed by Solventum Corporation - Quantisnow
Solventum reaffirms 2025 guidance, and announces long-range plan through 2028 - MSN
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy - Yahoo Finance
Stifel maintains Buy rating and $88 target on Solventum stock By Investing.com - Investing.com Canada
Mizuho Securities Raises Price Target on Solventum to $85 From $82, Keeps Neutral Rating - Marketscreener.com
Stifel maintains Buy rating and $88 target on Solventum stock - Investing.com
Analysts Have Conflicting Sentiments on These NA Companies: Solventum Corporation (SOLV) and ZEEKR Intelligent Technology Holding Limited Sponsored ADR (ZK) - The Globe and Mail
Mizuho raises Solventum stock target to $85, maintains neutral By Investing.com - Investing.com South Africa
Mizuho raises Solventum stock target to $85, maintains neutral - Investing.com
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
Solventum offers new details on layoffs and plans for growth - Mass Device
Solventum outlines growth strategy at 2025 Investor Day By Investing.com - Investing.com South Africa
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day - PR Newswire
Should You Invest in Solventum Corporation (SOLV)? - Insider Monkey
Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy - MSN
Thermo Fisher to Acquire Solventum’s Purification and Filtration Business - The Healthcare Technology Report.
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum launches electronic sterilisation testing system - MSN
Jones Financial Companies Lllp Grows Stock Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Thermo Fisher Strikes Deal for Solventum’s Filtration Unit - MSN
Agree To Buy Solventum At $50, Earn 2.9% Annualized Using Options - Nasdaq
Solventum Launches Attest™ eBowie-Dick Test System Revolutionizi - GuruFocus.com
Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance - Nasdaq
March 2025 DE Pearls for Your Practice - Dental Economics
Charles Schwab Investment Management Inc. Has $75.92 Million Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Mutual of America Capital Management LLC Sells 461 Shares of Solventum Co. (NYSE:SOLV) - Defense World
Oppenheimer & Co. Inc. Has $272,000 Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Reviewing Solventum (SOLV) and Its Rivals - Defense World
Solventum (NYSE:SOLV) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Solventum Co. (NYSE:SOLV) Shares Sold by US Bancorp DE - MarketBeat
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Morgan Stanley Adjusts Price Target on Solventum to $80 From $73, Maintains Equalweight Rating - Marketscreener.com
Solventum Co. (NYSE:SOLV) Stock Position Lifted by Bank of New York Mellon Corp - Defense World
Head-To-Head Contrast: Solventum (SOLV) vs. Its Peers - Defense World
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.37%
자본화:
|
볼륨(24시간):